Leading with Authenticity: How Health Equity and DEI Builds Communities and Impact Reputation

Session details:

As DEI priorities face external pressures and shifting corporate commitments, pharma and biotech industries are at a critical inflection point. This session explores how inclusive practices are not just values-driven, but also business critical. As we see shifts in initiatives, how can pharma and biotech companies evolving their DEI efforts to drive real impact—both internally, by shaping culture and leadership, and externally, by building deeper connections with underserved patient communities.

• Examine how authentic, action-oriented DEI strategies contribute to stronger reputations with external stakeholders, better business outcomes, and more equitable access to innovation.
• Learn how inclusive communication plays a vital role in addressing healthcare disparities and earning community trust.